R0V.F
Revenio Group Oyj

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

245.73M USD

Market Cap

511.26M USD

Margin of Safety

-108.1%

Intrinsic / Market Ratio

0.48×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

268.35M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

239.31M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

229.54M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

245.73M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

245.73M USD

from the sum above

Market Cap

511.26M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.48×

the ratio the screener ranks by; Margin of Safety -108.1% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 268.35M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)259.43M USD
+②Net Cash Today8.92M USD
+③Growth Value0 USD
=Value268.35M USD

EPV of the Operations (NOPAT over WACC)

259.43M USD

Net cash today

+8.92M USD

Growth Value

0 USD

Value

268.35M USD

①EPV (earnings power value)

259.43M USD

②Net Cash Today

8.92M USD

③Growth Value

0 USD

Market value

Market Cap511.26M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-90.5%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 239.31M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE162.86M USD
+②Equity at Year 15, Today76.44M USD
=Value239.31M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

162.86M USD

②Equity at Year 15, Today

76.44M USD

Market value

Market Cap511.26M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-113.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 229.54M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF168.22M USD
+②Invested Capital at Year 15, Today52.40M USD
+③Net Cash Today8.92M USD
=Value229.54M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

168.22M USD

②Invested Capital at Year 15, Today

52.40M USD

③Net Cash Today

8.92M USD

Market value

Market Cap511.26M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-122.7%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.86%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.92×Market Risk Premium 6.00%= 10.01%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 6.37M USDPretax Income 26.84M USD= 23.72%

The tax the interest saves.

Interest Expense =EBIT 27.30M USD−Pretax Income 26.84M USD= 456.25K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 456.25K USDTotal Debt 11.43M USD×(1 − Tax Rate for WACC 23.72%)= 3.04%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 11.43M USDMarket Cap + Total Debt 511.26M USD + 11.43M USD= 2.19%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 97.81%×Cost of Equity 10.01%+Debt Weight 2.19%×Cost of Debt 3.04%= 9.86%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 547.89M USD − Total Liabilities 376.96M USD = Book Value Today 170.93M USD

Total Debt 11.43M USD − Cash and Short-Term Investments 20.35M USD = Net Debt Today -8.92M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 19.4%at most 5%does not pass34,736,570 / 31,753,455
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.8%at least -10.0%passes(35.55M USD − 20.47M USD) ÷ 547.89M USD
Price to bookMarket Cap ÷ Book Value Today2.99×at most 3×passes511.26M USD ÷ 170.93M USD
Operating marginOperating Income ÷ Revenue23.2%above 10.0%passes29.88M USD ÷ 128.97M USD
Revenue growthRevenue ÷ Revenue a Year Before − 119.6%above 10.0%passes128.97M USD / 107.83M USD
Net cash(Cash − Total Debt) ÷ Market Cap1.7%above -30%passes(20.35M USD − 11.43M USD) ÷ 511.26M USD
Operating efficiencyOperating Income ÷ Gross Profit32.7%above 25.0%passes29.88M USD ÷ 91.49M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

10.83 EUR

Enterprise value

566.17M EUR

the provider's own figure

EV / EBITDA

28.14×

Price / book

2.17×

the provider's book

Price / earnings

26.39×

Return on equity

10.3%

the provider's figure, not this page's

Profit margin

10.5%

Revenue growth

49.8%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

103.49M107.00M107.83M128.97M

Gross profit

74.45M75.60M75.98M91.49M

Operating income

31.67M29.18M26.09M29.88M

EBITDA

operating income before depreciation and amortisation

34.95M33.30M31.77M32.58M

Pretax income

31.01M28.12M25.65M26.84M

Net income

23.21M21.17M19.27M20.47M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

23.21M21.17M19.27M20.47M

R&D

3.41M3.16M2.79M2.39M
Balance sheet, year end

Total assets

145.23M152.24M147.22M177.15M

Total liabilities

48.21M41.57M35.03M42.27M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

97.02M110.68M112.20M134.88M

Total debt

21.55M19.85M13.32M12.92M

Cash and equivalents

34.21M23.87M21.55M30.86M

Net PP&E

fixed assets after depreciation

4.86M6.60M5.21M8.45M

Working capital

current assets less current liabilities

28.64M30.04M26.45M31.80M
Cash flow

Operating cash flow

24.80M12.03M24.87M35.55M

Capital expenditure

paid out, so below zero

-2.13M-4.51M-4.34M-4.91M

Depreciation and amortisation

3.66M4.37M5.41M5.28M

Free cash flow

operating cash flow plus capital expenditure

22.67M7.52M20.53M30.64M